Marktgröße und Marktanteil von Next Generation Sequencing (NGS) in der klinischen Onkologie bis 2025 – 2031
Clinical Oncology Next Generation Sequencing (NGS) Market Report Analysis
Clinical Oncology Next Generation Sequencing (NGS) Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Agilent Technologies, Inc.
- Caris Life Sciences
- F. Hoffmann-La Roche Ltd
- FOUNDATION MEDICINE, INC.
- Illumina, Inc.
- Myriad Genetics, Inc.
- Oxford Nanopore Technologies
- PerkinElmer Inc
- QIAGEN
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Mittlerer Osten und Afrika
Market Segmentation
By Technologie
- Sequenzierung des gesamten Exoms
- Sequenzierung des gesamten Genoms
- gezielte Sequenzierung und Neusequenzierung
By Arbeitsablauf
- NGS-Datenanalyse
- NGS-Vorsequenzierung
- NGS-Sequenzierung
By Anwendung
- Begleitdiagnostik
- Screening
- andere Anwendungen
By Endbenutzer
- Krankenhäuser und Kliniken
- Labore
Get Free Sample For